Newsroom
PGxperts™ Bytes: Medication Safety, Survey Readiness, and the Role of PGx in Long-Term Care
AccessDx Laboratory partner, YouScript, is excited to announce the next PGxperts™ Bytes - a series of short discussions covering important topics across the pharmacogenomics space. Host Joel Diamond, CMO of…
Read More
PGxperts™ Bytes: The Case for DPYD Testing
AccessDx Laboratory partner, YouScript, is excited to announce the next PGxperts™ Bytes - a series of short discussions covering important topics across the pharmacogenomics space. Host Joel Diamond, CMO of…
Read More
DPYD Safety Update: Reducing the Risk of Critical or Fatal Chemotherapy Side Effects
Aranscia® solutions help oncologists comply with new FDA warning label requiring DPYD genetic testing in patients receiving select chemotherapies HOUSTON, Oct. 16, 2025 /PRNewswire/ -- Oncologists and pharmacy experts are reacting to last…
Read More
AccessDx Lab to Exhibit at NCDONA 2025
AccessDx Laboratory is exhibiting at the upcoming NCDONA 29th Annual Conference. The conference is taking place in Myrtle Beach, SC on September 10-12, 2025 with the theme “Where Will Your…
Read More
Personalized prescribing in long-term care: Why it matters more than ever
Polypharmacy, adverse drug events, the Beers Criteria, and pain management. "Personalized prescribing in long-term care: Why it matters more than ever," by Joel Diamond, CMO of AccessDx Laboratory, in McKnight's…
Read More
PGxperts™ Bytes: Selecting a Quality PGx Partner
AccessDx Laboratory partner, YouScript, is excited to announce the next PGxperts™ Bytes - a series of short discussions covering important topics across the pharmacogenomics space. Host Kristine Ashcraft, President and…
Read More
Spartanburg Regional Healthcare System (SRHS) Selects AccessDx Laboratory as Pharmacogenomics (PGx) Program Partner
Collaboration empowers clinicians with personalized insights and furthers health equity in precision medicine SPARTANBURG, S.C. and HOUSTON, July 2, 2025 /PRNewswire/ -- Spartanburg Regional Healthcare System (SRHS) has selected AccessDx…
Read More
Understanding Behavioral and Psychological Symptoms of Dementia
By: Houda Hachad, PharmD, M. Res, Vice President of Clinical Operations Understanding Behavioral and Psychological Symptoms of Dementia Behavioral and psychological symptoms of dementia (BPSD), also known as neuropsychiatric symptoms,…
Read More
Neurogen Biomarking Announces Partnership with Aranscia
Aranscia Diagnostic Laboratory and Technology Solutions Support Neurogen's Innovative Platform for the Early Detection of Mild Cognitive Impairment (MCI) and Alzheimer's Dementia CHICAGO and HOUSTON, May 21, 2025 /PRNewswire/ --…
Read More
Pharmacogenomic Testing as a Preventive Approach to Tardive Dyskinesia Risk Reduction and Management
By: Houda Hachad, PharmD, M. Res, Vice President of Clinical Operations Understanding Tardive Dyskinesia Tardive dyskinesia (TD) is a chronic, potentially irreversible movement disorder caused by prolonged use of dopamine…
Read More
AccessDx Laboratory Hosting a Panel Session at PointClickCare SUMMIT
AccessDx Laboratory invites attendees of the 2025 PointClickCare SUMMIT to join us for "Advancing Care with Personalized Medication Management" alongside our partners, PharMerica and HCF Management Inc. Attendees will learn…
Read More
AccessDx Laboratory Announces Integration with PointClickCare
Streamlined Access to Proven Precision Care Solutions to Help Improve Resident Care HOUSTON, Feb. 19, 2025 /PRNewswire/ -- AccessDx Laboratory, a nationwide provider of precision medicine and diagnostics solutions, today…
Read More
AccessDx Lab to Exhibit at the 2024 PointClickCare SUMMIT
AccessDx Laboratory is exhibiting and speaking at the upcoming 2025 PointClickCare SUMMIT. The conference is taking place in Las Vegas, NV on March 31 - April 2. We invite attendees…
Read More
AccessDx Lab to Exhibit at the 2024 Psych Congress
AccessDx Laboratory is exhibiting at the upcoming 2024 Psych Congress, hosted by HMP Global. The conference is taking place in Boston, MA on October 29 - November 2. We invite…
Read More
Research Update: PharmVar GeneFocus: CYP4F2
This month, “PharmVar GeneFocus: CYP4F2” was released in the ASCPT's journal, Clinical Pharmacology & Therapeutics Volume 116, Issue 4 featuring Jessica Savieo, Senior Clinical Implementation Specialist at AccessDx Laboratory, alongside…
Read More
Expert Briefing: Navigating the Surge in Respiratory Infections
We invite you to join Dr. Joel Diamond, Chief Medical Officer at Aranscia, for an exclusive 20-minute briefing covering the latest news and insights into respiratory infection cases, COVID-19 trends,…
Read More
AccessDx Lab to Exhibit at TXADONA 2024
AccessDx Laboratory is exhibiting at the upcoming TXADONA 2024 State Conference. The conference is taking place in Dallas, TX on September 25-26, 2024. We invite attendees of the conference to…
Read More
AccessDx Lab to Exhibit at SNN RETHINK 2024
AccessDx Laboratory is exhibiting at the upcoming SNN RETHINK Conference. The conference is taking place in Chicago, IL on September 11-12, 2024. We invite attendees of the conference to meet…
Read More
AccessDx Lab to Exhibit at NCDONA 2024
AccessDx Laboratory is exhibiting at the upcoming NCDONA 28th Annual Conference. The conference is taking place in Myrtle Beach, SC on September 11-13, 2024 with the theme “Oh the Places…
Read More
AccessDx Lab to Exhibit at VHCA/VCAL 2024
AccessDx Laboratory is exhibiting at the upcoming 2024 VHCA/VCAL Annual Convention & Trade Show. The conference is taking place in Norfolk, VA on September 9-12, 2024 with the theme “Sailing…
Read More
AccessDx Lab to Exhibit and Speak at IHCA/ICAL’s Annual Convention and Expo
AccessDx Laboratory is exhibiting at the upcoming 2024 IHCA/ICAL 74th Annual Convention & Expo. The conference is taking place in Peoria, Illinois on September 9-12, 2024 with the theme “Playbook…
Read More
